Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency,Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07024823
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Who this might be right for
Chronic Kidney Disease
AstraZeneca 124
Large-scale testing (Phase 3)Study completedNCT00800683
What this trial is testing

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 133
Not applicableLooking for participantsNCT05692388
What this trial is testing

Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Who this might be right for
Diabetic Nephropathy Type 2 - UncontrolledDiabetes Mellitus, Type 2Chronic Kidney Diseases
Medical College of Wisconsin 330
Early research (Phase 1)Ended earlyNCT02008851
What this trial is testing

A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes

Who this might be right for
Chronic Kidney Disease
Tengion 1
Testing effectiveness (Phase 2)Study completedNCT05018416
What this trial is testing

Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)

Who this might be right for
Chronic Kidney DiseasesType 1 Diabetes MellitusType 2 Diabetes Mellitus
Prokidney 53
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Testing effectiveness (Phase 2)Study completedNCT01043029
What this trial is testing

Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 302
Not applicableStudy completedNCT03157960
What this trial is testing

Effect of Acute Fructose Load in Human

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2
Karolinska University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02358096
What this trial is testing

Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Astellas Pharma Europe B.V. 125
Large-scale testing (Phase 3)Ended earlyNCT00555217
What this trial is testing

VA NEPHRON-D: Diabetes iN Nephropathy Study

Who this might be right for
Kidney DiseaseNephropathyType 2 Diabetes
US Department of Veterans Affairs 1,448
Not applicableStudy completedNCT03921242
What this trial is testing

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Weill Medical College of Cornell University 4,888
Not applicableStudy completedNCT04190251
What this trial is testing

PANDIA IRIS: Patients With Diabetes and Kidney Failure, an Interdisciplinary Medication Adherence Support Program

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency, Chronic
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 73
Testing effectiveness (Phase 2)Study completedNCT05254002
What this trial is testing

Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Bayer 1,664
Not applicableStudy completedNCT04006028
What this trial is testing

Kidney Biopsy Indications in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes, Chronic Kidney Disease
Rennes University Hospital 500
Not applicableStudy completedNCT07672639
What this trial is testing

Development and Validation of a Machine Learning Model for Differentiating Diabetic Kidney Disease and Non-Diabetic Kidney Disease in Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 2 DiabetesChronic Kidney Disease
Beijing Tongren Hospital 2,201
Post-approval studies (Phase 4)UnknownNCT01978405
What this trial is testing

Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes

Who this might be right for
Acute Kidney InjuryThe Changes of Plasma CreatinineThe Changes of Plasma Free Radicals+1 more
Xiang Guang-da 200
Large-scale testing (Phase 3)Study completedNCT05998837
What this trial is testing

GLUcose Transport and REnalPROtection in Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseDiabetes Mellitus, Type 2Hypertension
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 34
Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Large-scale testing (Phase 3)Not Yet RecruitingNCT06820567
What this trial is testing

Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD

Who this might be right for
Chronic Kidney DiseasesDiabetes Type 2
Assiut University 210
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Next Page